Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2009. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Fesoterodine fumarate | Is a | Fesoterodine (substance) | false | Inferred relationship | Some | ||
| Fesoterodine fumarate | Has disposition (attribute) | Muscarinic receptor antagonist (disposition) | true | Inferred relationship | Some | ||
| Fesoterodine fumarate | Is a | Muscarinic receptor antagonist | true | Inferred relationship | Some | ||
| Fesoterodine fumarate | Is modification of (attribute) | Fesoterodine (substance) | true | Inferred relationship | Some | ||
| Fesoterodine fumarate | Is a | Smooth muscle relaxant (substance) | true | Inferred relationship | Some | ||
| Fesoterodine fumarate | Is a | Acetylcholine receptor antagonist | false | Inferred relationship | Some | ||
| Fesoterodine fumarate | Is a | Diarylmethane (substance) | true | Inferred relationship | Some | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Fesoterodine fumarate 8 mg prolonged-release oral tablet | Has precise active ingredient | True | Fesoterodine fumarate | Inferred relationship | Some | 1 | 
| Fesoterodine fumarate 8 mg prolonged-release oral tablet | Has basis of strength substance (attribute) | True | Fesoterodine fumarate | Inferred relationship | Some | 1 | 
| Product containing precisely fesoterodine fumarate 4 milligram/1 each prolonged-release oral tablet (clinical drug) | Has precise active ingredient | True | Fesoterodine fumarate | Inferred relationship | Some | 1 | 
| Product containing precisely fesoterodine fumarate 4 milligram/1 each prolonged-release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Fesoterodine fumarate | Inferred relationship | Some | 1 | 
This concept is not in any reference sets